首页> 外国专利> Use of a compound of the 5-ht1a agonist because it serves to prepare a Medicine for the treatment of disorders of the Outer retina, such as Macular Degeneration associated with age.Retinitis pigmentosa, among others.

Use of a compound of the 5-ht1a agonist because it serves to prepare a Medicine for the treatment of disorders of the Outer retina, such as Macular Degeneration associated with age.Retinitis pigmentosa, among others.

机译：5-ht1a激动剂化合物的用途，因为它可用于制备治疗外视网膜疾病的药物，例如与年龄有关的黄斑变性，色素性视网膜炎等。

页面导航

摘要
著录项
相似文献

摘要

With 5-ht1a activity compounds useful in the treatment of disorders of the Outer retina.

机译：具有5-ht1a活性的化合物可用于治疗外视网膜疾病。

著录项

公开/公告号CL2001000597A1

专利类型
公开/公告日2002-02-27

原文格式PDF
申请/专利权人 ALCON INC.;
展开▼

申请/专利号CL2001000597
发明设计人 COLLIER ROBERT J.;HELLBERG MARK R.;KAPIN MICHAEL A.;DEANTHOMAS R.;
展开▼

申请日2001-03-15
分类号A61K31/137;A61K31/404;A61K31/428;A61K31/438;A61K31/4433;A61K31/4439;A61K31/445;A61K31/451;A61K31/4545;A61K31/4745;A61K31/496;A61K31/506;A61P27/02;A61P27/06;
国家 CL
入库时间 2022-08-22 00:45:53

相似文献

专利
外文文献
中文文献